Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2

Comparison of Cell Fusions Induced by Influenza Virus and SARS-CoV-2

Virus–cell fusion is the key step for viral infection in host cells. Studies on virus binding and fusion with host cells are important for understanding the virus–host interaction and viral pathogenesis for the discovery of antiviral drugs. In this review, we focus on the virus–cell fusions induced...

Full description

Bibliographic Details
Main Authors:	Chuyuan Zhang, Xinjie Meng, Hanjun Zhao
Format:	Article
Language:	English
Published:	MDPI AG 2022-07-01
Series:	International Journal of Molecular Sciences
Subjects:	cell fusions fusion inhibitors influenza virus SARS-CoV-2
Online Access:	https://www.mdpi.com/1422-0067/23/13/7365

Similar Items

Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation
by: Shiu-Wan Chan
Published: (2022-11-01)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
by: Zeinab Abdelrahman, et al.
Published: (2020-09-01)

SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
by: Shuai Xia, et al.
Published: (2023-12-01)

Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants
by: Danwei Yu, et al.
Published: (2021-01-01)

The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner
by: Mizuki Yamamoto, et al.
Published: (2020-06-01)

SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection
by: Carla Zannella, et al.
Published: (2023-12-01)

Detection and Differentiation of SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses by CRISPR
by: Huifen Zhou, et al.
Published: (2021-05-01)

SARS-CoV-2 fusion-inhibitory lipopeptides maintain high potency against divergent variants of concern including Omicron
by: Yuanmei Zhu, et al.
Published: (2022-12-01)

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
by: Ralph A. Tripp, et al.
Published: (2022-03-01)

SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus
by: Katherine Elizabeth Havranek, et al.
Published: (2020-12-01)

Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern
by: Katharina S. Schmitz, et al.
Published: (2022-06-01)

Molecular Modeling of Viral Type I Fusion Proteins: Inhibitors of Influenza Virus Hemagglutinin and the Spike Protein of Coronavirus
by: Sophia S. Borisevich, et al.
Published: (2023-03-01)

Recovery from Triple Infection with SARS-CoV-2, RSV and Influenza virus: A case report
by: Giacomo Guido, et al.
Published: (2023-07-01)

SARS-CoV-2 Protein S Fusion Peptide Is Capable of Wrapping Negatively-Charged Phospholipids
by: José Villalaín
Published: (2023-03-01)

Outbreak of Influenza and Other Respiratory Viruses in Hospitalized Patients Alongside the SARS-CoV-2 Pandemic
by: Ilana S. Fratty, et al.
Published: (2022-06-01)

Plant-derived Ren's oligopeptide has antiviral effects on influenza virus and SARS-CoV-2
by: Chengzhi Yu, et al.
Published: (2023-02-01)

Transient Excursions to Membrane Core as Determinants of Influenza Virus Fusion Peptide Activity
by: Remigiusz Worch, et al.
Published: (2021-05-01)

Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line
by: Alexander A. Dolskiy, et al.
Published: (2020-12-01)

NMR structure and localization of a large fragment of the SARS-CoV fusion protein : implications in viral cell fusion
by: Pillay, Shubhadra, et al.
Published: (2019)

Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection
by: Masaaki Miyazawa
Published: (2020-10-01)

Simultaneous detection and differentiation of SARS-CoV-2, influenza A virus and influenza B virus by one-step quadruplex real-time RT-PCR in patients with clinical manifestations
by: Minjun Ni, et al.
Published: (2021-02-01)

Estimating the impact of influenza on the epidemiological dynamics of SARS-CoV-2
by: Matthieu Domenech de Cellès, et al.
Published: (2021-12-01)

Co-infection with SARS-CoV-2 and influenza A virus
by: Shuhei Azekawa, et al.
Published: (2020-01-01)

Small Molecule Inhibitors of Influenza Virus Entry
by: Zhaoyu Chen, et al.
Published: (2021-06-01)

Influenza Virus-Mediated Membrane Fusion: Determinants of Hemagglutinin Fusogenic Activity and Experimental Approaches for Assessing Virus Fusion
by: Susan Daniel, et al.
Published: (2012-07-01)

Full-Length Computational Model of the SARS-CoV-2 Spike Protein and Its Implications for a Viral Membrane Fusion Mechanism
by: Wataru Nishima, et al.
Published: (2021-06-01)

A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana
by: Jennifer L. Miatech, et al.
Published: (2020-01-01)

Dysregulated Inflammation During Obesity: Driving Disease Severity in Influenza Virus and SARS-CoV-2 Infections
by: Katina D. Hulme, et al.
Published: (2021-10-01)

Ectodomain Pulling Combines with Fusion Peptide Inserting to Provide Cooperative Fusion for Influenza Virus and HIV
by: Sergey A. Akimov, et al.
Published: (2020-07-01)

Decreased Levels of SARS-CoV-2 Fusion-Inhibitory Antibodies in the Serum of Aged COVID-19 Patients
by: Astrid Malézieux-Picard, et al.
Published: (2022-07-01)

Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses
by: Ramireddy Bommireddy, et al.
Published: (2022-06-01)

Optimized quantification of intra-host viral diversity in SARS-CoV-2 and influenza virus sequence data
by: A. E. Roder, et al.
Published: (2023-08-01)

Methylation Pathways and SARS-CoV-2 Lung Infiltration and Cell Membrane-Virus Fusion Are Both Subject to Epigenetics
by: Leo Pruimboom, et al.
Published: (2020-05-01)

Protective Role of Combined Polyphenols and Micronutrients against Influenza A Virus and SARS-CoV-2 Infection In Vitro
by: Marta De Angelis, et al.
Published: (2021-11-01)

Aerosol Transmission of the Pandemic SARS-CoV-2 and Influenza A Virus Was Blocked by Negative Ions
by: Cheng Zhang, et al.
Published: (2022-04-01)

Structural understanding of SARS-CoV-2 virus entry to host cells
by: Kim Le, et al.
Published: (2023-11-01)

Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern
by: Emiel Vanhulle, et al.
Published: (2022-08-01)

Assay System for Simultaneous Detection of SARS-CoV-2 and Other Respiratory Viruses
by: Ho-Jae Lim, et al.
Published: (2021-06-01)

Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus
by: Pontus Hedberg, et al.
Published: (2022-01-01)

Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza
by: Ekaterina Stepanova, et al.
Published: (2024-04-01)